Pure Clinical at MEDICA 2025 – four days of meetings, trends, and new opportunities ⚕️ Pure Clinical

Pure Clinical at MEDICA 2025 – four days of meetings, trends, and new opportunities

This year’s edition of MEDICA | Trade Fair for Medical Technology & Healthcare was exceptionally productive for Pure Clinical. Our delegation — Katarzyna Szatraj, PhD, and Fryderyk Janiak — spent four intensive days meeting innovators, manufacturers, and distributors to talk about clinical investigations, regulatory strategies, IVD performance studies, and certification processes.

Conversations on clinical trials, certification, and market access

Most discussions focused on upcoming clinical investigations, MDR/IVDR compliance, IVD performance studies, and EU market entry strategies. Many companies sought practical guidance on choosing the optimal regulatory pathway — an area where Pure Clinical’s experience proved highly valuable.

Active presence across exhibition halls

Katarzyna Szatraj and Fryderyk Janiak visited numerous booths, meeting industry leaders as well as emerging innovators. These interactions provided insights into new MedTech solutions, SaMD developments, and future cooperation opportunities.

Final day full of conclusions and plans for 2026

The final day of MEDICA 2025 allowed our team to summarize key insights and outline potential future collaborations. Many discussions revolved around clinical trial planning for 2026, certification preparation, and global market expansion.